Fasting and Postprandial Glucose In a clinical pharmacology study in patients with type 2 diabetes mellitus, treatment with once weekly TRULICITY resulted in a reduction of fasting and 2-hour PPG concentrations, and postprandial serum glucose incremental AUC, when compared to placebo (-25.6 mg/dL, -59.5 mg/dL, and -197 mg*h/dL, respectively)
Potential Benefits: Treats Sexual Dysfunction: Effective in treating sexual dysfunction in both men and women, including erectile dysfunction and hypoactive sexual desire disorder
Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery
Rybelsus demonstrated 44% greater A1c reduction than the placebo
Macrolides (Azithromycin and Clarithromycin) Clarithromycin, in particular, has been noted in some clinical reports to potentially increase the effects of diabetes medications
One RCT, investigating semaglutide, demonstrated that it significantly reduced cravings and the number of drinks with an initial dose of 0.25 mg [26]